Karyopharm Therapeutics Inc.
KPTIQ· OTC
Released Nov 2, 2017, after the close
10-Q filed Nov 2, 2017, 33 days after period end · 0001564590-17-021223
No earnings release is on file for this quarter. Its figures came with the 10-Q.
| Metric | Q3 2017 | Q3 2016 | Q3 2015 | Q3 2014 |
|---|---|---|---|---|
| Revenue | $0.00 | $48.00K | $75.00K | $21.00K |
| Net Income | -$30.64M | -$25.43M | -$30.37M | -$19.72M |
| EPS Diluted | -$0.65 |
Karyopharm Therapeutics Inc. · CIK 1503802 · Engraved from SEC EDGAR
| -$0.69 |
| -$0.85 |
| -$0.61 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.